We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Oxygen Therapy May Pose Risk for Heart Attack Patients

By HospiMedica staff writers
Posted on 27 Mar 2007
There is little clinical evidence to support the routine use of oxygen in myocardial infarction (MI), and it may actually be detrimental, according to a new study.

Researchers at the Medical Research Institute of New Zealand (MRINZ, Wellington) conducted an historical review of literature on the use of oxygen therapy in MI since 1950. More...
Among the findings was the fact that the only randomized, double-blind and controlled trial of oxygen therapy in the first 24 hours of myocardial infarction in 1976 showed that patients receiving routine oxygen therapy ended up having a greater amount of heart damage than those receiving room air. The likely reason for this observation was provided in a 2005 study in which the administration of high flow oxygen was shown to reduce coronary artery blood flow in stable patients with heart disease. The researchers concluded the review in a call to challenge the current clinical dogma of oxygen administration in MI and perform urgent research on the issue. The review was published in the March 2007 issue of the Journal of the Royal Society of Medicine.

"Use of oxygen to relieve angina has been available for 100 years. However, as far back as 1950, researchers have been cautioning about its routine use in myocardial infarction,” said lead author Professor Richard Beasley, M.D., director of the MRINZ. "Research in this area is scarce but cardiologists should be concerned as the balance of evidence suggests that its routine use in this clinical situation may cause harm.”

"For over 50 years and especially in the 1980s and 1990s, research has focused on the pharmacological agents in myocardial infarction and we have ignored the impact of routine oxygen use, despite earlier warnings,” continued Professor Beasley. "Oxygen therapy should only be given if the oxygen level is significantly reduced, which is uncommon in the situation of a heart attack.”


Related Links:
Medical Research Institute of New Zealand

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.